MetaCap

Atrium Therapeutics Insider Trades

NASDAQ: RNAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

6.92-0.06 (-0.86%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Atrium Therapeutics insider activity

Over the last 12 months, Atrium Therapeutics insiders reported 14 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Flanagan W. Michael (Director) reporting a transaction in 22,812 shares at $8.95 on Sep 18, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RNA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

RNA insider transactions

Atrium Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Sep 18, 2026Hoyos Rocio MartinChief Strategy OfficerTax withholding8,320$74.46KForm 4
Sep 18, 2026Winslow Brendan R.Chief Financial OfficerTax withholding6,742$60.34KForm 4
Sep 18, 2026Gallagher Kathleen P.See RemarksTax withholding11,632$104.11KForm 4
Sep 18, 2026Kenney StephanieSee RemarksTax withholding2,375$21.26KForm 4
Sep 18, 2026Hughes Steven GeorgeChief Medical OfficerTax withholding21,459$192.06KForm 4
Sep 18, 2026Younis HusamChief Scientific OfficerTax withholding11,216$100.38KForm 4
Sep 18, 2026Boyce SarahDirectorTax withholding126,418$1.13MForm 4
Sep 18, 2026Flanagan W. MichaelDirectorTax withholding22,812$204.17KForm 4
Apr 20, 2026Hoyos Rocio MartinChief Strategy OfficerAward30,000—Form 4
Apr 20, 2026Hughes Steven GeorgeChief Medical OfficerAward30,000—Form 4
Apr 20, 2026Younis HusamChief Scientific OfficerAward30,000—Form 4
Apr 20, 2026Gallagher Kathleen P.See RemarksAward102,500—Form 4
Apr 20, 2026Winslow Brendan R.Chief Financial OfficerAward30,000—Form 4
Apr 20, 2026Kenney StephanieSee RemarksAward30,000—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related